Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'constitutive activity' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chidiac, P
      Considerations in the evaluation of inverse agonism and protean agonism atG protein-coupled receptors

      G PROTEIN PATHWAYS, PT A, RECEPTORS
    2. Seifert, R; Wenzel-Seifert, K
      Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state

      RECEPTORS & CHANNELS
    3. Wurch, T; Pauwels, PJ
      Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and G alpha protein subunits

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    4. Albert, PR; Tiberi, M
      Receptor signaling and structure: insights from serotonin-1 receptors

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    5. Passani, MB; Cangioli, L; Baldi, E; Bucherelli, C; Mannaioni, PF; Blandina, P
      Histamine H-3 receptor-mediated impairment of contextual fear conditioningand in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala

      EUROPEAN JOURNAL OF NEUROSCIENCE
    6. Pouzet, B; Serradeil-Le Gal, C; Bouby, N; Maffrand, JP; Le Fur, G; Bankir, L
      Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    7. Schwartz, JC; Morisset, S; Rouleau, A; Tardivel-Lacombe, J; Gbahou, F; Ligneau, X; Heron, A; Sasse, A; Stark, H; Schunack, W; Ganellin, RC; Arrang, JM
      Application of genomics to drug design: the example of the histamine H-3 receptor

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    8. Kenakin, T
      Inverse, protean, and ligand-selective agonism: matters of receptor conformation

      FASEB JOURNAL
    9. Bullock, CM; Li, C; Li, M; Bermak, JC; Zhou, QY
      Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: Inverse agonism by D2 receptor antagonists

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    10. Nie, JJ; Lewis, DL
      Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration

      JOURNAL OF NEUROSCIENCE
    11. Sieving, PA; Fowler, ML; Bush, RA; Machida, S; Calvert, PD; Green, DG; Makino, CL; McHenry, CL
      Constitutive "light" adaptation in rods from G90D rhodopsin: A mechanism for human congenital nightblindness without rod cell loss

      JOURNAL OF NEUROSCIENCE
    12. Niefind, K; Guerra, B; Ermakowa, I; Issinger, OG
      Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme

      EMBO JOURNAL
    13. Kohen, R; Fashingbauer, LA; Heidmann, DEA; Guthrie, CR; Hamblin, MW
      Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop

      MOLECULAR BRAIN RESEARCH
    14. Strange, PG
      Antipsychotic drugs: Importance of dopamine receptors for mechanisms of therapeutic actions and side effects

      PHARMACOLOGICAL REVIEWS
    15. Audinot, V; Newman-Tancredi, A; Millan, MJ
      Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms

      NEUROPHARMACOLOGY
    16. Ango, F; Prezeau, L; Muller, T; Tu, JC; Xiao, B; Worley, PF; Pin, JP; Bockaert, J; Fagni, L
      Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer

      NATURE
    17. Carroll, FY; Stolle, A; Beart, PM; Voerste, A; Brabet, I; Mauler, F; Joly, C; Antonicek, H; Bockaert, J; Muller, T; Pin, JP; Prezau, L
      BAY36-7620: A potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

      MOLECULAR PHARMACOLOGY
    18. Liu, CL; Wilson, SJ; Kuei, C; Lovenberg, TW
      Comparison of human, mouse, rat, and guinea pig histamine H-4 receptors reveals substantial pharmacological species variation

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Dupre, DJ; Le Gouill, C; Rola-Pleszczynski, M; Stankova, J
      Inverse agonist activity of selected ligands of platelet-activating factorreceptor

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    20. Zaki, PA; Keith, DE; Thomas, JB; Carroll, FI; Evans, CJ
      Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    21. Seifert, R
      Monovalent anions differentially modulate coupling of the beta(2)-adrenoceptor to G(s alpha) splice variants

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    22. Morse, KL; Behan, J; Laz, TM; West, RE; Greenfeder, SA; Anthes, JC; Umland, S; Wan, YT; Hipkin, RW; Gonsiorek, W; Shin, N; Gustafson, EL; Qiao, XD; Wang, SK; Hedrick, JA; Greene, J; Bayne, M; Monsma, FJ
      Cloning and characterization of a novel human histamine receptor

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    23. Wang, DX; Raehal, KM; Bilsky, EJ; Sadee, W
      Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence

      JOURNAL OF NEUROCHEMISTRY
    24. Wilson, J; Lin, H; Fu, DY; Javitch, JA; Strange, PG
      Mechanisms of inverse agonism of antipsychotic drugs at the D-2 dopamine receptor: use of a mutant D-2 dopamine receptor that adopts the activated conformation

      JOURNAL OF NEUROCHEMISTRY
    25. Palanche, T; Ilien, B; Zoffmann, S; Reck, MP; Bucher, B; Edelstein, SJ; Galzi, JL
      The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states

      JOURNAL OF BIOLOGICAL CHEMISTRY
    26. Mizoue, LS; Sullivan, SK; King, DS; Kledal, TN; Schwartz, TW; Bacon, KB; Handel, TM
      Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine

      JOURNAL OF BIOLOGICAL CHEMISTRY
    27. de Vries, B; Roffel, AF; Zaagsma, J; Meurs, H
      Effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on contractile receptor function in airway smooth muscle

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Hoffmann, M; Verzijl, D; Lundstrom, K; Simmen, U; Alewijnse, AE; Timmerman, H; Leurs, R
      Recombinant Semliki Forest virus for over-expression and pharmacological characterisation of the histamine H-2 receptor in mammalian cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Ramsay, D; Bevan, N; Rees, S; Milligan, G
      Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor

      BRITISH JOURNAL OF PHARMACOLOGY
    30. Christopoulos, A; Coles, P; Lay, L; Lew, MJ; Angus, JA
      Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens

      BRITISH JOURNAL OF PHARMACOLOGY
    31. Biebermann, H; Schoneberg, T; Krude, H; Gudermann, T; Gruters, A
      Constitutively activating TSH-receptor mutations as a molecular cause of non-autoimmune hyperthyroidism in childhood

      LANGENBECKS ARCHIVES OF SURGERY
    32. Dosil, M; Schandel, KA; Gupta, E; Jenness, DD; Konopka, JB
      The C terminus of the Saccharomyces cerevisiae alpha-factor receptor contributes to the formation of preactivation complexes with its cognate G protein

      MOLECULAR AND CELLULAR BIOLOGY
    33. Yoon, J; Ben-Ami, HC; Hong, YS; Park, S; Strong, LLR; Bowman, J; Geng, CX; Baek, K; Minke, B; Pak, WL
      Novel mechanism of massive photoreceptor degeneration caused by mutations in the trp gene of Drosophila

      JOURNAL OF NEUROSCIENCE
    34. Burford, NT; Wang, DX; Sadee, W
      G-protein coupling of mu-opioid receptors (OP3): elevated basal signallingactivity

      BIOCHEMICAL JOURNAL
    35. Chen, SH; Lin, F; Xu, M; Hwa, J; Graham, RM
      Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation

      EMBO JOURNAL
    36. Rosendorff, A; Ebersole, BJ; Sealfon, SC
      Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor

      MOLECULAR BRAIN RESEARCH
    37. Yanagisawa, T; Sato, T; Yamada, H; Sukegawa, J; Nunoki, K
      Selectivity and potency of agonists for the three subtypes of cloned humanbeta-adrenoceptors expressed in Chinese hamster ovary cells

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    38. Tian, WN; Deth, RC
      Differences in efficacy and Na+ sensitivity between alpha(2B) and alpha(2D) adrenergic receptors - Implications for R and R* states

      PHARMACOLOGY
    39. Zhou, YY; Yang, D; Zhu, WZ; Zhang, SJ; Wang, DJ; Rohrer, DK; Devic, E; Kobilka, BK; Lakatta, EG; Cheng, HP; Xiao, RP
      Spontaneous activation of beta 2-but not beta(1)-adrenoceptors expressed in cardiac myocytes from beta(1)beta(2) double knockout mice

      MOLECULAR PHARMACOLOGY
    40. Holst, B; Elling, CE; Schwartz, TW
      Partial agonism through a zinc-ion switch constructed between transmembrane domains III and VII in the tachykinin NK1 receptor

      MOLECULAR PHARMACOLOGY
    41. Vanhauwe, JFM; Josson, K; Luyten, WHML; Driessen, AJ; Leysen, JE
      G-protein sensitivity of ligand binding to human dopamine D-2 and D-3 receptors expressed in Escherichia coli: Clues for a constrained D-3 receptor structure

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    42. Fanelli, F
      Theoretical study on mutation-induced activation of the luteinizing hormone receptor

      JOURNAL OF MOLECULAR BIOLOGY
    43. Unson, CG; Wu, CR; Sakmar, TP; Merrifield, RB
      Selective stabilization of the high affinity binding conformation of glucagon receptor by the long splice variant of G alpha(s)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Hasegawa, H; Katoh, H; Yamaguchi, Y; Nakamura, K; Futakawa, S; Negishi, M
      Different membrane targeting of prostaglandin EP3 receptor isoforms dependent on their carboxy-terminal tail structures

      FEBS LETTERS
    45. Jackson, A; Iwasiow, RM; Tiberi, M
      Distinct function of the cytoplasmic tail in human D1-like receptor ligandbinding and coupling

      FEBS LETTERS
    46. Cao, YJ; Gimpl, G; Fahrenholz, F
      A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation

      FEBS LETTERS
    47. Cosi, C; Koek, W
      The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    48. Bakker, RA; Wieland, K; Timmerman, H; Leurs, R
      Constitutive activity of the histamine H-1 receptor reveals inverse agonism of histamine H-1 receptor antagonists

      EUROPEAN JOURNAL OF PHARMACOLOGY
    49. de Vries, B; Meurs, H; Roffel, AF; Elzinga, CRS; Hoiting, BH; de Vries, MML; Zaagsma, J
      beta-agonist-induced constitutive beta(2)-adrenergic receptor activity in bovine tracheal smooth muscle

      BRITISH JOURNAL OF PHARMACOLOGY
    50. Zhu, J; Taniguchi, T; Takauji, R; Suzuki, F; Tanaka, T; Muramatsu, I
      Inverse agonism and neutral antagonism at a constitutively active alpha-1aadrenoceptor

      BRITISH JOURNAL OF PHARMACOLOGY
    51. Hopkinson, HE; Latif, ML; Hill, SJ
      Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors

      BRITISH JOURNAL OF PHARMACOLOGY
    52. Zaltsman, I; Grimberg, H; Lupu-Meiri, M; Lifshitz, I; Oron, Y
      Rapid desensitization of the TRH receptor and persistent desensitization of its constitutively active mutant

      BRITISH JOURNAL OF PHARMACOLOGY
    53. de Ligt, RAF; Kourounakis, AP; Ijzerman, AP
      Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery

      BRITISH JOURNAL OF PHARMACOLOGY
    54. Pauwels, PJ
      Diverse signalling by 5-hydroxytryptamine (5-HT) receptors

      BIOCHEMICAL PHARMACOLOGY
    55. Chen, G; Jayawickreme, C; Way, J; Armour, S; Queen, K; Watson, C; Ignar, D; Chen, WJ; Kenakin, T
      Constitutive receptor systems for drug discovery

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    56. Millan, MJ; Gobert, A; Audinot, V; Dekeyne, A; Newman-Tancredi, A
      Inverse agonists and serotonergic transmission: From recombinant, human serotonin (5-HT)(1B) receptors to G-protein coupling and function in corticolimbic structures in vivo

      NEUROPSYCHOPHARMACOLOGY
    57. Cetani, F; Tonacchera, M; Pinchera, A; Barsacchi, R; Basolo, F; Miccoli, P; Pacini, F
      Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    58. Cavalli, A; Babey, AM; Loh, HH
      Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor

      NEUROSCIENCE
    59. Strange, PE
      Agonism and inverse agonism at dopamine D-2-like receptors

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    60. Strange, PG
      Mechanisms of action of anti-psychotic drugs

      BIOCHEMICAL SOCIETY TRANSACTIONS
    61. Grotewiel, MS; Sanders-Bush, E
      Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptorsrevealed by heterologous expression

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    62. Cai, GP; Gurdal, H; Smith, C; Wang, HY; Friedman, E
      Inverse agonist properties of dopaminergic antagonists at the D-1A dopamine receptor: Uncoupling of the D-1A dopamine receptor from G(s) protein

      MOLECULAR PHARMACOLOGY
    63. Seifert, R; Gether, U; Wenzel-Seifert, K; Kobilka, BK
      Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: Evidence for multiple receptor conformations

      MOLECULAR PHARMACOLOGY
    64. Schipani, E; Langman, C; Hunzelman, J; Le Merrer, M; Loke, KY; Dillon, MJ; Silve, C; Juppner, H
      A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation inJansen's metaphyseal chondrodysplasia

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    65. Hasegawa, H; Fujita, H; Katoh, H; Aoki, J; Nakamura, K; Ichikawa, A; Negishi, M
      Opposite regulation of transepithelial electrical resistance and paracellular permeability by Rho in Madin-Darby canine kidney cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    66. Cypess, AM; Unson, CG; Wu, CR; Sakmar, TP
      Two cytoplasmic loops of the glucagon receptor are required to elevate cAMP or intracellular calcium

      JOURNAL OF BIOLOGICAL CHEMISTRY
    67. Lattion, AL; Abuin, L; Nenniger-Tosato, M; Cotecchia, S
      Constitutively active mutants of the beta 1-adrenergic receptor

      FEBS LETTERS
    68. Wise, H
      Characterization of chimeric prostacyclin/prostaglandin D-2 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    69. Neilan, CL; Akil, H; Woods, JH; Traynor, JR
      Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists

      BRITISH JOURNAL OF PHARMACOLOGY
    70. Grimberg, H; Zaltsman, I; Lupu-Meiri, M; Gershengorn, MC; Oron, Y
      Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C

      BRITISH JOURNAL OF PHARMACOLOGY
    71. Daeffler, L; Schmidlin, F; Gies, JP; Landry, Y
      Inverse agonist activity of pirenzepine at M-2 muscarinic acetylcholine receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    72. Meyer-Kirchrath, J; Hasse, A; Schror, K
      Preservation of G(i) coupling of a chimeric EP3/I-type prostaglandin (IP) receptor

      BIOCHEMICAL PHARMACOLOGY
    73. Yoshida, A; Ueda, H
      Activation of G(i1) by lysophosphatidic acid receptor without ligand in the baculovirus expression system

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    74. BIEBERMANN H; SCHONEBERG T; SCHULZ A; KRAUSE G; GRUTERS A; SCHULTZ G; GUDERMANN T
      A CONSERVED TYROSINE RESIDUE (Y601) IN TRANSMEMBRANE DOMAIN-5 OF THE HUMAN THYROTROPIN RECEPTOR SERVES AS A MOLECULAR SWITCH TO DETERMINE G-PROTEIN COUPLING

      The FASEB journal
    75. SUGAMORI KS; SCHEIDELER MA; VERNIER P; NIZNIK HB
      DOPAMINE D1B RECEPTOR CHIMERAS REVEAL MODULATION OF PARTIAL AGONIST ACTIVITY BY CARBOXYL-TERMINAL TAIL SEQUENCES

      Journal of neurochemistry
    76. ALEWIJNSE AE; SMIT MJ; HOFFMANN M; VERZIJL D; TIMMERMAN H; LEURS R
      CONSTITUTIVE ACTIVITY AND STRUCTURAL INSTABILITY OF THE WILD-TYPE HUMAN H-2-RECEPTOR

      Journal of neurochemistry
    77. BEINBORN M; QUINN SM; KOPIN AS
      MINOR MODIFICATIONS OF A CHOLECYSTOKININ-B GASTRIN RECEPTOR NONPEPTIDE ANTAGONIST CONFER A BROAD-SPECTRUM OF FUNCTIONAL-PROPERTIES/

      The Journal of biological chemistry
    78. SELKIRK JV; SCOTT C; HO M; BURTON MJ; WATSON J; GASTER LM; COLLIN L; JONES BJ; MIDDLEMISS DN; PRICE GW
      SB-224289 - A NOVEL SELECTIVE (HUMAN) 5-HT1B RECEPTOR ANTAGONIST WITHNEGATIVE INTRINSIC ACTIVITY

      British Journal of Pharmacology
    79. THOMAS DR; GITTINS SA; COLLIN LL; MIDDLEMISS DN; RILEY G; HAGAN J; GLOGER I; ELLIS CE; FORBES IT; BROWN AM
      FUNCTIONAL-CHARACTERIZATION OF THE HUMAN CLONED 5-HT7 RECEPTOR (LONG FORM) - ANTAGONIST PROFILE OF SB-258719

      British Journal of Pharmacology
    80. PORCELLINI A; FENZI G; AVVEDIMENTO EV
      MUTATIONS OF THYROTROPIN RECEPTOR GENE

      Journal of molecular medicine
    81. NANOFF C; FREISSMUTH M
      COUPLING COFACTOR - A NOVEL REGULATORY COMPONENT IN G-PROTEIN-MEDIATED SIGNALING

      Physiologia bohemoslovaca
    82. DREMIER S; POHL V; POTEETSMITH C; ROGER PP; CORBIN J; DOSKELAND SO; DUMONT JE; MAENHAUT C
      ACTIVATION OF CYCLIC-AMP-DEPENDENT KINASE IS REQUIRED BUT MAY NOT BE SUFFICIENT TO MIMIC CYCLIC-AMP-DEPENDENT DNA-SYNTHESIS AND THYROGLOBULIN EXPRESSION IN DOG THYROID-CELLS

      Molecular and cellular biology
    83. MERKOURIS M; MULLANEY I; GEORGOUSSI Z; MILLIGAN G
      REGULATION OF SPONTANEOUS ACTIVITY OF THE DELTA-OPIOID RECEPTOR - STUDIES OF INVERSE AGONISM IN INTACT-CELLS

      Journal of neurochemistry
    84. HERRICKDAVIS K; EGAN C; TEITLER M
      ACTIVATING MUTATIONS OF THE SEROTONIN 5-HT2C RECEPTOR

      Journal of neurochemistry
    85. ALEWIJNSE AE; SMIT MJ; PENA MSR; VERZIJL D; TIMMERMAN H; LEURS R
      MODULATION OF FORSKOLIN-MEDIATED ADENYLYL-CYCLASE ACTIVATION BY CONSTITUTIVELY ACTIVE G(S)-COUPLED RECEPTORS

      FEBS letters
    86. HIZAKI H; HASEGAWA H; KATOH H; NEGISHI M; ICHIKAWA A
      FUNCTIONAL-ROLE OF CARBOXYL-TERMINAL TAIL OF PROSTAGLANDIN EP3 RECEPTOR IN GI COUPLING

      FEBS letters
    87. MARY S; STEPHAN D; GOMEZA J; BOCKAERT J; PRUSS RM; PIN JP
      THE RAT MGLU(1D) RECEPTOR SPLICE VARIANT SHARES FUNCTIONAL-PROPERTIESWITH THE OTHER SHORT ISOFORMS OF MGLU(1) RECEPTOR

      European journal of pharmacology
    88. JIN JG; MAO GF; ASHBY B
      CONSTITUTIVE ACTIVITY OF HUMAN PROSTAGLANDIN-E RECEPTOR EP3 ISOFORMS

      British Journal of Pharmacology
    89. NEWMANTANCREDI A; CONTE C; CHAPUT C; SPEDDING M; MILLAN MJ
      INHIBITION OF THE CONSTITUTIVE ACTIVITY OF HUMAN 5-HT1A-RECEPTORS BY THE INVERSE AGONIST, SPIPERONE BUT NOT THE NEUTRAL ANTAGONIST, WAY-100635

      British Journal of Pharmacology
    90. RAO VR; OPRIAN DD
      ACTIVATING MUTATIONS OF RHODOPSIN AND OTHER G-PROTEIN-COUPLED RECEPTORS

      Annual review of biophysics and biomolecular structure
    91. LEDENT C; COPPEE F; DUMONT JE; VASSART G; PARMENTIER M
      TRANSGENIC MODELS FOR PROLIFERATIVE AND HYPERFUNCTIONAL THYROID-DISEASES

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    92. VANSANDE J; MASSART C; COSTAGLIOLA S; ALLGEIER A; CETANI F; VASSART G; DUMONT JE
      SPECIFIC ACTIVATION OF THE THYROTROPIN RECEPTOR BY TRYPSIN

      Molecular and cellular endocrinology
    93. NEGISHI M; HASEGAWA H; ICHIKAWA A
      PROSTAGLANDIN-E RECEPTOR EP3-GAMMA ISOFORM, WITH MOSTLY FULL CONSTITUTIVE GI ACTIVITY AND AGONIST-DEPENDENT GS ACTIVITY

      FEBS letters
    94. CETANI F; TONACCHERA M; VASSART G
      DIFFERENTIAL-EFFECTS OF NACL CONCENTRATION ON THE CONSTITUTIVE ACTIVITY OF THE THYROTROPIN AND THE LUTEINIZING-HORMONE CHORIONIC-GONADOTROPIN RECEPTORS

      FEBS letters
    95. TONACCHERA M; CETANI F; COSTAGLIOLA S; VANSANDE J; REFETOFF S; VASSART G
      FUNCTIONAL-CHARACTERISTICS OF A VARIANT THYROTROPIN RECEPTOR

      European journal of biochemistry
    96. BURSTEIN ES; SPALDING TA; BRANN MR
      CONSTITUTIVE ACTIVATION OF CHIMERIC M2 M5 MUSCARINIC RECEPTORS AND DELINEATION OF G-PROTEIN COUPLING SELECTIVITY DOMAINS/

      Biochemical pharmacology
    97. IMASAKI K; OKABE T; MURAKAMI H; FUJITA K; TAKAYANAGI R; NAWATA H
      PREMATURE TERMINATION MUTATION ((772)GLU-]STOP) IN THE HORMONE-BINDING DOMAIN OF THE ANDROGEN RECEPTOR IN A PATIENT WITH THE RECEPTOR-NEGATIVE FORM OF COMPLETE ANDROGEN INSENSITIVITY SYNDROME

      Endocrine journal
    98. TIBERI M; CARON MG
      CONSTITUTIVE ACTIVITY OF DOPAMINE D1-RECEPTOR SUBTYPES

      Clinical neuropharmacology
    99. JAKUBIK J; BACAKOVA L; ELFAKAHANY EE; TUCEK S
      CONSTITUTIVE ACTIVITY OF THE M(1)M(4) SUBTYPES OF MUSCARINIC RECEPTORS IN TRANSFECTED CHO CELLS AND OF MUSCARINIC RECEPTORS IN THE HEART-CELLS REVEALED BY NEGATIVE ANTAGONISTS

      FEBS letters
    100. BURSTEIN ES; SPALDING TA; BRAUNEROSBORNE H; BRANN MR
      CONSTITUTIVE ACTIVATION OF MUSCARINIC RECEPTORS BY THE G-PROTEIN G(Q)

      FEBS letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 11:42:24